Evidence map›Paper›PMID 37061047›Full record

ArticleThe Journal of hospital infection2023

Infection prevention and control between legal requirements and German Society for Hygiene and Microbiology expert assessments: a cross-sectional study in September-November 2022.

A A Mardiko, J Buer, A M Köster, H E J Kaba, F Mattner, J Zweigner, N T Mutters, N von Maltzahn, R Leistner, T Eckmanns and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of hospital infection, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 1 country.

A A MardikoDepartment of Infection Control and Infectious Diseases, University Medical Centre Göttingen, Göttingen, Germany.
J BuerInstitute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
A M KösterDepartment of Infection Control and Infectious Diseases, University Medical Centre Göttingen, Göttingen, Germany.
H E J KabaDepartment of Infection Control and Infectious Diseases, University Medical Centre Göttingen, Göttingen, Germany.
F MattnerInstitute for Hygiene, Cologne Merheim Medical Centre, University Witten-Herdecke, Witten, Germany.
J ZweignerDepartment of Infection Control and Hospital Hygiene, University Hospital Cologne, Cologne, Germany.
N T MuttersInstitute for Hygiene and Public Health, University Hospital Bonn, Bonn, Germany.
N von MaltzahnInstitute for Medical Microbiology and Hospital Epidemiology, Medical School Hanover, Hanover, Germany.
R LeistnerInstitute of Hygiene and Environmental Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany; Division of Gastroenterology, Infectious Diseases and Rheumatology, Medical Department, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
T EckmannsDivision of Nosocomial Infection, Surveillance of Antibiotic Resistance and Consumption, Robert Koch Institute, Berlin, Germany.
C BrandtSection for Hospital and Environmental Hygiene, Centre for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.
S ScheithauerDepartment of Infection Control and Infectious Diseases, University Medical Centre Göttingen, Göttingen, Germany. Electronic address: simone.scheithauer@med.uni-goettingen.de.
Humboldt-Universität zu Berlin · DEMedizinische Hochschule Hannover · DERobert Koch Institute · DEUniversity Hospital Bonn · DEUniversity Hospital Cologne · DEUniversity Hospital Heidelberg · DEUniversity of Duisburg-Essen · DEWitten/Herdecke University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn contrast to the beginning of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), pandemic, more and more hospital issues are now regulated by policy.

aimTo identify differences between expert recommendations and legal requirements regarding infection prevention and control (IPC) strategies.

methodsA cross-sectional study was conducted between 29

findingsThe majority (66%) of experts recommended universal mask usage, with 34% recommending it seasonally, even after the SARS-CoV-2 pandemic. Medical microbiology (MM) experts were more likely to recommend continuing to wear the masks indefinitely compared with IPC experts. Concerning the mask type, medical masks were recommended more frequently by IPC experts (47.3%), while FFP2 masks were preferred by MM experts (31.8%). The majority (54.7%) of experts recommended universal screening of employees, mainly in settings with extremely vulnerable patients and if regional incidence rates were high, at a frequency of twice per week. The dominant advice (recommended by at least 50% of experts) for employees exposed to SARS-CoV-2 was daily testing and wearing a mask, regardless of the length of exposure.

conclusionsExpert recommendations deviate from the legal requirements and appear to be more differentiated and proportional. The influence of specific experience and expertise on mask recommendations should be investigated in more detail. For relevant policy decisions, a quick, focused and broad-based consultation of expertise could be of added value.

Indexed as

COVID-19SARS-CoV-2Cross-Sectional StudiesHumansHygieneInfection ControlHealthcare workersHospital hygieneInfection prevention and controlMaskSARS-CoV-2Staff workloadsUniversal screening

Identifiers

PMID37061047
PMCPMC10101543
OpenAlexW4365458766

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.